Cactus Acquisition CORP 1 LTD

Market Movers (8-K)

See all →
OTC.Pink
Cactus Acquisition Corp. 1 Limited announced the immediate resignation of independent director Rainer Michael for personal reasons, with no disagreements cited.
OTC.Pink
Cactus Acquisition Corp. 1 Limited shareholders approved an extension to November 2, 2026, for its business combination, but faced significant share redemptions.
Delay expected
Worse than expected
OTC.Pink
Cactus Acquisition Corp. 1 Limited announced the resignation of independent director Jeff LeBlanc from its Board of Directors, effective June 18, 2025, citing personal reasons and no disagreements with the company.
OTC.Pink
Cactus Acquisition Corp. 1 Limited has announced the resignation of its CEO and the appointment of a new CEO and independent director, effective November 29, 2024.
OTC.Pink
Cactus Acquisition Corp. 1 Ltd. has successfully extended its deadline to complete a business combination to November 2, 2025, following a shareholder vote.
OTC.Pink
Cactus Acquisition Corp. 1 Limited received a delisting notice from Nasdaq due to not completing a business combination within the required timeframe, and will move to the OTC market while still pursuing its merger with Tembo E-LV B.V.
Worse than expected

Quarterly Earnings (10-Q)

See all →
OTC.Pink
Cactus Acquisition Corp. 1 Ltd. extended its business combination deadline to November 2, 2026, but faces substantial doubt about its ability to continue as a going concern amid significant share redemptions and a working capital deficiency.
Delay expected
Worse than expected
Capital raise
OTC.Pink
Cactus Acquisition Corp. 1 reports a net loss, significant capital deficiency, and ongoing reliance on financing as it pursues a business combination with Tembo e-LV B.V. amidst a Nasdaq delisting.
Worse than expected
Delay expected
Capital raise
OTC.Pink
Cactus Acquisition Corp. 1 Ltd. reported a net loss in Q1 2025 as it continues efforts to finalize its business combination with Tembo e-LV B.V. despite Nasdaq delisting and ongoing liquidity concerns.
Delay expected
Worse than expected
Capital raise
OTC.Pink
Cactus Acquisition Corp. 1 Ltd. released its Q3 2024 financial results, highlighting ongoing efforts to finalize a business combination with Tembo e-LV B.V. and a subsequent delisting from NASDAQ.
Worse than expected
Delay expected
Capital raise
OTC.Pink
Cactus Acquisition Corp. 1 Ltd. released its Q2 2024 financial results, highlighting ongoing efforts to secure a business combination while navigating sponsor transitions and Nasdaq compliance requirements.
Worse than expected
Delay expected
Capital raise
OTC.Pink
Cactus Acquisition Corp. 1 Ltd. released its first quarter 2024 results, highlighting a net profit of $37,000 and strategic changes including a shift in focus to emerging technology companies.
Worse than expected
Capital raise

Annual Reports (10-K)

OTC.Pink
Cactus Acquisition Corp. 1 Ltd. has filed its annual report for the fiscal year ended December 31, 2025, detailing its ongoing efforts to complete a business combination with Tembo e-LV B.V. and its delisting from Nasdaq.
Delay expected
Capital raise
OTC.Pink
Cactus Acquisition Corp. 1 Ltd.'s annual report reveals delisting from Nasdaq, a business combination agreement with Tembo e-LV B.V., and substantial doubt about its ability to continue as a going concern.
Capital raise
Worse than expected
OTC.Pink
Cactus Acquisition Corp. 1 Ltd.'s 10-K filing details the company's registered securities, including Class A and Class B ordinary shares, warrants, and units, as of March 31, 2024.

Insider Trading (Form 4)

See all →
OTC.Pink
VivoPower's subsidiary, Tembo, has confidentially submitted its F-4 registration statement to the SEC, marking a significant step towards its Nasdaq listing.
Capital raise
OTC.Pink
Cactus Acquisition Corp. 1 Ltd. secured shareholder approval to extend the deadline for completing an initial business combination to November 2, 2025, while facing significant share redemptions.
Worse than expected
OTC.Pink
Cactus Acquisition Corp. 1 Ltd. (CCTS) has entered into a Business Combination Agreement with Tembo e-LV B.V., valuing Tembo at $838 million, to be paid in newly issued ordinary shares of Holdco.
OTC.Pink
Cactus Acquisition Corp. 1 Ltd. (CCTS) has entered into a definitive Business Combination Agreement with Tembo e-LV, valuing the combined entity at $904 million, assuming no redemptions by CCTS public shareholders.
OTC.Pink
Director Jeff LeBlanc of Cactus Acquisition Corp. 1 Ltd purchased 100,000 Class A ordinary shares at $0.50 each on July 29, 2024.
OTC.Pink
ARWM Inc Pte. Ltd., a 10% owner of Cactus Acquisition Corp. 1 Ltd, sold 100,000 Class A ordinary shares at $0.50 each on July 29, 2024.

Proxy Statements (Def-14A)

OTC.Pink
Cactus Acquisition Corp. 1 Limited is seeking shareholder approval to extend its business combination deadline by one year to November 2, 2026, to finalize its merger with Tembo e-LV B.V.
Worse than expected
Delay expected
OTC.Pink
Cactus Acquisition Corp. 1 Limited is seeking shareholder approval to extend the deadline for completing a business combination from November 2, 2024, to November 2, 2025, and has entered into a non-redemption agreement to limit potential fund outflows.
Delay expected
OTC.Pink
Cactus Acquisition Corp. 1 Limited is seeking shareholder approval to extend the deadline for completing a business combination from November 2, 2024, to November 2, 2025, to finalize its merger with Tembo e-LV.

Schedule 13G - Passive Investments

OTC.Pink
Kepos Capital LP and Mark Carhart have filed an amended Schedule 13G, reporting 0% beneficial ownership of Cactus Acquisition Corp. 1 Ltd. Class A ordinary shares.
Worse than expected
OTC.Pink
Kepos Capital LP and Mark Carhart have disclosed a 5.1% beneficial ownership stake in Cactus Acquisition Corp. 1 Ltd, holding 200,000 Class A ordinary shares.